Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)

NCT01961414 is registered in ClinicalTrials.gov with Palmetto Retina Center, LLC as lead sponsor.

NCT NCT01961414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01961414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat and Extend Therapy Using Intravitreal Aflibercept (IAI) for Previously Treated Patients Exiting the Wet Age-related Macular Degeneration Extension Study (0910)
Lead sponsor
Palmetto Retina Center, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2013
Completion date
July 31, 2016
Enrollment
45 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age-related macular degeneration